NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $365,168 | +0.9% | 3,585 | 0.0% | 0.14% | +6.1% |
Q2 2023 | $361,762 | +9.7% | 3,585 | 0.0% | 0.13% | +4.0% |
Q1 2023 | $329,820 | +3.9% | 3,585 | +2.4% | 0.13% | -3.1% |
Q4 2022 | $317,520 | +19.4% | 3,500 | 0.0% | 0.13% | +8.3% |
Q3 2022 | $266,000 | -10.1% | 3,500 | 0.0% | 0.12% | -9.8% |
Q2 2022 | $296,000 | +13.8% | 3,500 | +18.2% | 0.13% | +26.7% |
Q1 2022 | $260,000 | – | 2,960 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |